A new appetite suppressant AN 448 was given to 41 adult obese out patients to investigate its effect on weight reduction with special references to the plasma lipids. Twelve of them dropped out within 4 weeks because of side effects or unknown reasons. The remaining 29 subjects lost their weights with an average reduction of 2.6 kg in a month and 5.9 kg in 3 months. Slight decrease in serum cholesterol, triglyceride, free fatty acids, phospholipid were also observed 1 month after administration.

